Qinghua Han
Dados Biográficos
| ID | 7311161 |
|---|---|
| NOME | Qinghua Han |
| PRENOMES | Qinghua |
| SOBRENOME | Han |
| ASSINATURA | HAN Q |
| AFILIAÇÕES | Peking University |
| ORCID | 0000-0002-9099-2327 |
| VERIFICADO | Não |
| TOTAL DE OBRAS | 2 |
| TOTAL DE CITAÇÕES | 0 |
| TOTAL COMO AUTOR | 2 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2018 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2025 |
| ÍNDICE H | 0 |
Efficacy and safety of Shexiang Baoxin Pill (Muskardia) in patients with stable coronary artery disease across different weight subgroups
MUSKARDIA plus OMT demonstrated promising efficacy and acceptable safety in CAD patients weighing less than 65 kg, potentially reducing the risk of MACEs. For patients weighing 65 kg or more, further investigation is needed to optimize dosing strategies
Total saponins of Albiziae Cortex show anti-hepatoma carcinoma effects by inducing S phase arrest and mitochondrial apoptosis pathway activation
Sem obras proeminentes nesta página.
Total saponins of Albiziae Cortex show anti-hepatoma carcinoma effects by inducing S phase arrest and mitochondrial apoptosis pathway activation
Efficacy and safety of Shexiang Baoxin Pill (Muskardia) in patients with stable coronary artery disease across different weight subgroups
MUSKARDIA plus OMT demonstrated promising efficacy and acceptable safety in CAD patients weighing less than 65 kg, potentially reducing the risk of MACEs. For patients weighing 65 kg or more, further investigation is needed to optimize dosing strategies
Medicine (2 obras) · Pharmacology (2 obras) · Traditional medicine (2 obras) · Apoptosis (1 obras) · Biochemistry (1 obras) · Biology (1 obras) · Cardiac Imaging and Diagnostics (1 obras) · Cardiology (1 obras) · Chemistry (1 obras) · Coronary artery disease (1 obras)